Verona Pharma has claimed FDA approval for its ... killing more than three million people in 2019, according to World Health Organization (WHO) estimates. The massive number of patients with ...

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine, its ...

In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against the other stocks that soared on Tuesday. The stock market finished Tuesday’s trading on a ...

We recently published a list of 10 Best Multibagger Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against other ...

In the pre-market hours, Verona's stock is trading at $65.79 ... RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages ...